TABLE 4.
Clinical Outcomes
| Characteristic | N (%) or median (range)a |
| Hospital length of stay, d | 5 (3-27) |
| Vital statusb | |
| Alive | 22 (24.4) |
| Dead | 68 (75.6) |
| Progression (overall) | |
| No | 83 (92.2) |
| Yes | 7 (7.8) |
| Cumulative incidence of progression | |
| 1 yr after surgery | 4.6% (95% CI: 0.2%-9.0%) |
| 2 yr after surgery | 8.2% (95% CI: 2.3%-14.1%) |
| Median time to progression (mo) | 13.9 (3.9-23.4) |
| Management of progression | |
| Surgery + PORT | 5 |
| RT alone | 2 |
| Median follow-up from date of surgery (mo) | |
| Total | 14.2 (1.3-86.3) |
| Alive | 38.3 (1.9-86.3) |
| Deceased | 11.5 (1.3-76.1) |
| Overall survival from date of surgery, median and 95% CI (mo) | 14.8 (11.5-30.0) |
| Discharge destination | |
| Home | 78 (87) |
| Rehabilitation | 12 (13) |
| ECOG performance status at 6 mo postoperatively | |
| 0 | 10 (11) |
| 1 | 29 (32) |
| 2 | 16 (18) |
| 3 | 1 (1) |
| 4 | 0 (0) |
| 5 (dead) | 28 (31) |
| Unknown | 6 (7) |
| ECOG 12 mo postoperatively | |
| 0 | 11 (12) |
| 1 | 22 (24) |
| 2 | 7 (8) |
| 3 | 4 (4) |
| 4 | 0 (0) |
| 5 (deceased) | 40 (44) |
| Unknown | 6 (7) |
ECOG, Eastern Cooperative Oncology Group; CI, confidence interval; PORT, postoperative radiation therapy.
a
Unless otherwise specified.
b
Vital status at the end of study period.